Publication:
Real-World Experience With Ocrelizumab in Relapsing Multiple Sclerosis: Insights From the MSOCR-R Cohort, an MSbase Registry Sub-Study

Simple item page
dc.authorwosidVan Pesch, Vincent/Aak-9506-2020
dc.authorwosidOzakbas, Serkan/V-6427-2019
dc.authorwosidTerzi̇, Murat/Aaa-1284-2021
dc.authorwosidBoz, Cavit/Aar-2268-2020
dc.contributor.authorButzkueven, H.
dc.contributor.authorSpelman, T.
dc.contributor.authorOzakbas, S.
dc.contributor.authorBoz, C.
dc.contributor.authorBuzzard, K.
dc.contributor.authorSkibina, O.
dc.contributor.authorMuros-Le Rouzic, E.
dc.date.accessioned2025-12-11T00:47:49Z
dc.date.issued2021
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Butzkueven, H.; van der Walt, A.] Monash Univ, Dept Neurosci, Cent Clin Sch, Melbourne, Vic, Australia; [Butzkueven, H.; Spelman, T.] MSBase Fdn, Dept Neurol, Alfred Ctr, Melbourne, Vic, Australia; [Ozakbas, S.] Dokuz Eylul Univ, Izmir, Turkey; [Boz, C.] Karadeniz Tech Univ, KTU Med Fac Farabi Hosp, Trabzon, Turkey; [Buzzard, K.; Skibina, O.] Monash Univ, Eastern Hlth Clin Sch, Dept Neurosci, Melbourne, Vic, Australia; [Kalincik, T.] Univ Melbourne, Dept Med, CORe, Melbourne, Vic, Australia; [Kalincik, T.] Royal Melbourne Hosp, MS Ctr, Melbourne, Vic, Australia; [Alroughani, R.] Amiri Hosp, Kuwait, Kuwait; [Lechner-Scott, J.] Univ Newcastle, Newcastle, NSW, Australia; [Laureys, G.; Van Hijfte, L.] Ghent Univ Hosp, Ghent, Belgium; [Terzi, M.] Mayis Univ, Samsun, Turkey; [Van Pesch, V.] Catholic Univ Louvain, Clin Univ St Luc, Brussels, Belgium; [Grand'Maison, F.] Neuro Rive Sud, Greenfield Pk, PQ, Canada; [Barnett, M.] Univ Sydney, Brain & Mind Ctr, Sydney, NSW, Australia; [Kermode, A.] Univ Western Australia, Nedlands, WA, Australia; [Sanchez Menoyo, J. L.] Hosp Galdakao Usansolo, Galdakao, Spain; [Rojas, J. I.] Hosp Univ CEMIC, Beunos Aries, Argentina; [Skromne, E.] Hosp Angeles de las Lomas, Inst Mexicano Neurociencias, Valle De Las Palmas, Mexico; [Sotoca, J.] Hosp Univ Mutua Terrassa, Barcelona, Spain; [Dirks, P.; Liu, C.; Muros-Le Rouzic, E.] F Hoffmann La Roche Ltd, Basel, Switzerlanden_US
dc.description.woscitationindexScience Citation Index Expanded
dc.identifier.endpage106en_US
dc.identifier.issn1352-4585
dc.identifier.issn1477-0970
dc.identifier.scopusqualityQ1
dc.identifier.startpage104en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/39322
dc.identifier.volume27en_US
dc.identifier.wosWOS:000706771300159
dc.identifier.wosqualityQ1
dc.language.isoenen_US
dc.publisherSage Publications Ltden_US
dc.relation.ispartofMultiple Sclerosis Journalen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleReal-World Experience With Ocrelizumab in Relapsing Multiple Sclerosis: Insights From the MSOCR-R Cohort, an MSbase Registry Sub-Studyen_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Files

Collections

WoS İndeksli Yayınlar Koleksiyonu